Terms: = Colorectal cancer AND MYH11, ENSG00000133392, 4629 AND Prognosis
4 results:
1. Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer.
Lin Y; Jing X; Chen Z; Pan X; Xu D; Yu X; Zhong F; Zhao L; Yang C; Wang B; Wang S; Ye Y; Shen Z
Theranostics; 2023; 13(13):4574-4600. PubMed ID: 37649598
[No Abstract] [Full Text] [Related]
2. A Prognostic Model Based on Six Metabolism-Related Genes in colorectal cancer.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
[TBL] [Abstract] [Full Text] [Related]
3. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
4. Down-regulated myh11 expression correlates with poor prognosis in stage II and III colorectal cancer.
Wang RJ; Wu P; Cai GX; Wang ZM; Xu Y; Peng JJ; Sheng WQ; Lu HF; Cai SJ
Asian Pac J Cancer Prev; 2014; 15(17):7223-8. PubMed ID: 25227818
[TBL] [Abstract] [Full Text] [Related]
